solanezumab

Why Eli Lilly Execs Say Alzheimer's Drug Development Is Far From Dead
Forbes
Tue, 08/23/16 - 09:57 am
Eli Lilly
Alzheimer's disease
solanezumab
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Investors.com
Fri, 07/1/16 - 10:07 am
Eli Lilly
solanezumab
Alzheimer's disease
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Epclusa
Sanofi
Regeneron
Praluent
Will Eli Lilly's 11th-hour regulatory gambit salvage or sink its Alzheimer's drug?
Fierce Biotech
Tue, 03/22/16 - 10:02 am
Eli Lilly
Alzheimer's disease
solanezumab
Lilly Alzheimer's Study Change Piles Risk on Top of Risk
TheStreet.com
Tue, 03/15/16 - 10:18 pm
Eli Lilly
Alzheimer's disease
solanezumab
clinical trials
Prediction: A New Drug Will Soon Offer Hope in the Alzheimer’s Fight
Fortune
Tue, 12/1/15 - 01:12 pm
Eli Lilly
Alzheimer's disease
solanezumab
Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher
24/7 Wall St
Fri, 10/9/15 - 03:57 pm
Eli Lilly
solanezumab
evacetrapib
Alzheimer's disease
Eli Lilly’s Solanezumab: A Possible Cure for Alzheimer’s?
Yahoo/Market Realist
Tue, 07/28/15 - 10:20 am
Eli Lilly
solanezumab
Alzheimer's disease
Lilly says drug slows Alzheimer's in patients with mild disease
Yahoo/Reuters
Wed, 07/22/15 - 08:42 am
Eli Lilly
Alzheimer's disease
solanezumab
Will Trial Results for Lilly and Biogen Alzheimer’s Drugs be Hard to Forget?
WSJ Pharmalot
Mon, 07/20/15 - 11:01 pm
Eli Lilly
Biogen
clinical trials
Alzheimer's disease
aducanumab
solanezumab
Alzheimer’s Drug Is a Big Bet for Lilly
WSJ Online
Sat, 07/18/15 - 10:35 am
Eli Lilly
Alzheimer's disease
solanezumab
AAIC Is Coming: Here's What To Expect, Biogen And Eli Lilly Investors
Yahoo/Benzinga
Sun, 07/5/15 - 10:57 am
AAIC
Biogen
Eli Lilly
aducanumab
solanezumab
Lilly's Alzheimer's Game
Seeking Alpha
Sun, 06/28/15 - 11:32 am
Eli Lilly
Alzheimer's disease
solanezumab
Is Excitement Over Eli Lilly’s Alzheimer’s Drug Overdone?
Barron's
Fri, 06/12/15 - 10:50 pm
Eli Lilly
Alzheimer's disease
solanezumab
Lilly shares sizzle as investors await Alzheimer's data
Yahoo/Reuters
Fri, 06/12/15 - 09:33 am
Eli Lilly
Alzheimer's disease
solanezumab
Alzheimer's Needs Cures, Not Pyrrhic Victories
Motley Fool
Mon, 07/21/14 - 09:17 am
Alzheimer's disease
pimavanserin
Acadia
Sangamo BioSciences
Valeant Pharmaceuticals
Bexarotene
Merck
BACE inhibitors
AstraZeneca
solanezumab
Eli Lilly
Could These Potential Catalysts Drive Lilly Higher?
Motley Fool
Tue, 02/4/14 - 06:58 pm
Eli Lilly
Evista
Zyprexa
Cymbalta
generics
solanezumab
Alzheimer's disease
LY2963016
diabetes
empagliflozin
dulaglutide
Alzheimer's Disease Could Become the Next Frontier in Pharmaceutical Research
Motley Fool
Tue, 11/19/13 - 07:40 am
Alzheimer's disease
R&D
JNJ
Eli Lilly
Pfizer
Elan
General Electric
Vizamyl
Amyvid
bapineuzumab
solanezumab
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Motley Fool
Mon, 09/30/13 - 04:29 pm
Alzheimer's disease
LY2886721
Eli Lilly
MK-8931
Merck
bapineuzumab
JNJ
solanezumab
Gammagard
Baxter International
Merck Hopes Alzheimer's Drug Fares Better Than Competitors
TheStreet.com
Thu, 09/5/13 - 08:50 am
Merck
Alzheimer's disease
Pfizer
Eli Lilly
JNJ
bapineuzumab
solanezumab
BACE inhibitors
MK-8931
The Past, Present, and Future of Alzheimer’s Treatments
Motley Fool
Fri, 08/23/13 - 09:26 am
Alzheimer's disease
Aricept
Pfizer
Eisai
Actavis
Namenda
Eli Lilly
Forest Labs
bapineuzumab
JNJ
Elan
Perrigo Company
solanezumab
PBT2
Prana Biotechnology

Pages